Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 3,895,064 |
|
|||||
| News | - | ||||||
| Day High | 11.97 | Low High |
|||||
| Day Low | 11.41 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Iovance Biotherapeutics Inc | IOVA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.81 | 7.16% | 12.13 | 19:59:49 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 11.42 | 11.41 | 11.97 | 11.86 | 11.32 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 29,699 | 3,895,064 | $ 11.71 | $ 45,625,712 | - | 3.21 - 18.33 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:49 | formt | 100 | $ 12.13 | USD |
Iovance Biotherapeutics (IOVA) Options Flow Summary
Iovance Biotherapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 3.31B | 279.31M | - | 1.19M | -444.04M | -1.59 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Iovance Biotherapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IOVA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 11.79 | 12.135 | 11.01 | 11.62 | 3,908,878 | 0.34 | 2.88% |
| 1 Month | 14.81 | 15.18 | 11.01 | 13.02 | 4,450,585 | -2.68 | -18.10% |
| 3 Months | 8.20 | 18.33 | 7.60 | 13.82 | 9,245,612 | 3.93 | 47.93% |
| 6 Months | 3.33 | 18.33 | 3.2717 | 10.34 | 8,350,229 | 8.80 | 264.26% |
| 1 Year | 5.79 | 18.33 | 3.21 | 8.79 | 7,162,168 | 6.34 | 109.50% |
| 3 Years | 31.27 | 33.55 | 3.21 | 10.68 | 4,454,934 | -19.14 | -61.21% |
| 5 Years | 11.05 | 54.2081 | 3.21 | 14.32 | 3,294,537 | 1.08 | 9.77% |
Iovance Biotherapeutics Description
| Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company. The company focused on the development and commercialization of cell therapies as novel cancer immunotherapy products designed to harness the power of a patient's immune system to eradicate cancer cells. Its lead pipeline candidate, LN-145, is an adoptive cell therapy using tumor-infiltrating lymphocytes to treat patients with refractory metastatic melanoma. |
